Conditions & Recovery · Immunotherapy Updates · May 20, 2026

New marker may help identify patients with advanced prostate cancer more likely to benefit from immunotherapy - UT MD Anderson

Explore the original story for the publisher’s full reporting.

Originally published by Immunotherapy Updates. We curate and add context; they did the reporting.

Related learning